万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>泌尿学与肾脏学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>血液学

BLOOD PURIFICATION《血液净化》 (官网投稿)

简介
  • 期刊简称BLOOD PURIFICAT
  • 参考译名《血液净化》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率14.10%
  • 主要研究方向医学-HEMATOLOGY 血液学;UROLOGY & NEPHROLOGY 泌尿学与肾脏学

主要研究方向:

等待设置主要研究方向
医学-HEMATOLOGY 血液学;UROLOGY & NEPHROLOGY 泌尿学与肾脏学

BLOOD PURIFICATION《血液净化》(双月刊). Practical information on hemodialysis, hemofiltration, peritoneal dialysis, and apheresis is featured in this jour...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://www.karger.com/Journal/Home/223997

3、投稿网址:

https://www.manuscriptmanager.net/BPU?product_id=223997

4、官网邮箱:bpu@karger.com

5、官网电话:+41 61 306 1573

6、期刊刊期:双月刊,逢单月出版。

2021527日星期四

                             

 

投稿须知【官网信息】

 

Blood Purification

Author Guidelines

About the Journal

Aims and Scope

Practical information on hemodialysis, hemofiltration, peritoneal dialysis, and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival, but also patient comfort and disease improvement by prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces, and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists, and hospital staff involved in dialysis, apheresis, and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. Blood Purification also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists, and critical care physicians in order to expand the level of interaction between different disciplines and specialties.

Journal Sections

Clinical Engineering

Critical Care Nephrology

Pediatric Section

Peritoneal Dialysis

Hemodialysis

Article Types

Research Article

Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.

Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.

Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.

A downloadable template is available below.

Documents

Research Article (DOCX, 28.97 KB)

Word Count: max. 2,500 words

Review Article

Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.

A downloadable template is available below.

Documents

Review Article (DOCX, 23.75 KB)

Word Count: max. 5,000 words

Systematic Review

Systematic Reviews are literature reviews focused on a research question that synthesizes all high-quality research evidence relevant to that question. Systematic Reviews should be presented in the Introduction, Methods, Results, Discussion format. The subject must be clearly defined. The objective of a Systematic Review should be to arrive at an evidence-based conclusion. The Methods section should give a clear indication of the literature search strategy, data extraction procedure, grading of evidence, and kind of analysis used. We strongly encourage authors to comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

A downloadable template is available below.

Documents

Systematic Review (DOCX, 27.84 KB)

Case Report

Case Reports can present a case study, case report, or other description of a case. Case Reports present significant new insights or cases with an unusual and noteworthy course. Submissions can be based on a case or a number of similar cases. The most important aspect of the presentation is that it should provide a new perspective on a recognized clinical scenario or may represent an entirely new clinical condition. The novelty of the case(s) may lie in the phenotype, the presentation, the investigation, and/or the management. We strongly encourage authors to comply with the CARE guidelines.The manuscript must include a statement detailing that written informed consent for publication was obtained and from whom (e.g. “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”). If the patient has died, consent for publication must be obtained from their next of kin. If the patient described in the case report is a minor or vulnerable, then consent for publication must be obtained from the parent/legal guardian. The completed consent form must be made available to the Editor if requested, and will be treated confidentially.

A downloadable template is available below.

Documents

Case Report (DOCX, 27.01 KB)

Word Count: max. 500 words

Editorial

Editorials provide a viewpoint on specific articles or on general subjects directly relevant to the journal. Editorials are written by an editor or other member of the journal.

Editorials should not exceed 500 words

A downloadable template is available below.

Documents

Editorial (DOCX, 24.95 KB)

Word Count: max. 1,000 words

Letter

Letters may explore subjects related to matters discussed in the journal, providing the author’s perspective on a subject. Letters may discuss a recently published article and may lend support or constructively critique the article in line with the author’s experience. The editors reserve the right to share such letters to the authors of the article concerned prior to publication in order to permit response, ideally in the same issue of the journal. Letters should not include original data.

Letters should not exceed 2000 words and have a maximum 15 references & 1 figure/table

A downloadable template is available below.

Documents

Letter (DOCX, 24.24 KB)

Word Count: max. 500 words, 1 figure or table and max. 10 references

Methods Article

Methods Articles primarily describe methods or procedures used to perform an experiment or research rather than report the results of the research.

A downloadable template is available below.

Documents

Method Article (DOCX, 24.33 KB)

Word Count: max. 5,000 words

Other Types

Any manuscripts that do not adhere to any of the other available article types should be submitted under 'Other Types'. Further information should be provided in a cover letter.

Meta-Analysis

Works consisting of studies using a quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc. It is often an overview of clinical trials. We strongly encourage authors to comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

A downloadable template is available below.

Documents

Meta-Analysis (DOCX, 26.7 KB)

Contact Information

Should you have any problems with your submission, please contact the editorial office:

Franziska Stalder

Editorial Office 'Blood Purification'

S. Karger AG

PO Box

CH-4009 Basel (Switzerland)

Tel. +41 61 306 1573

Fax +41 61 306 1434

bpu@karger.com

Editorial and Journal Policies

General Conditions

Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.

All manuscripts are subject to editorial review.

The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).

Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.

By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author.

Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement.

Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/. Another widely used licensing tool is PLSClear. Please check the publishers websites for the available options and user instructions.

Statements

All submitted manuscripts must contain a Statement of Ethics, a Conflict of Interest Statement, an Author Contributions Statement and a Data Availability Statement after the main body of the text, but before the reference list.

Statement of Ethics

Published research must comply with internationally-accepted standards for research practice and reporting. Manuscripts may be rejected if the editors believe that the research has not been carried out within an appropriate ethical framework, and concerns raised after publication may lead to a correction, retraction, or expression of concern in line with COPE guidelines.

Studies involving human subjects (including research on identifiable human material and data) must have been performed with the approval of an appropriate ethics committee and with appropriate participants’ informed consent in compliance with the Helsinki Declaration.

In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate. If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision).

For all research involving human subjects, written informed consent to participate in the study should be obtained from participants (or their parent/legal guardian  where appropriate  ) and a statement detailing this should appear in the manuscript. For studies involving vulnerable participants or participants at risk of potential coercion, detailed information regarding the steps taken to ensure informed consent must be provided. If consent was not obtained, please specify why and whether this was approved by the ethics committee.

In line with the ICMJE recommendations on the protection of research participants, authors must avoid providing identifying information unless strictly necessary for the submission and participants’ identifiable attributes must be anonymized in the manuscript and its supplementary files, if any. If identifying information is necessary, authors must confirm that the individual has provided written consent for the use of that information in a publication.

……

更多详情:

https://www.karger.com/Journal/Guidelines/223997


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭